Links

Tools

Export citation

Search in Google Scholar

Metalloproteases as mediators of therapy resistance in glioblastoma

Published in 2015 by Michael Eibach, Jörg W. Bartsch, Uwe Schlomann, Catharina Conrad, Barbara Carl, Christopher Nimsky
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload

Abstract

Objective: GBM adjuvant therapy using radiotherapy and/or Temozolomide (TMZ) remains inefficient due to resistance mechanisms. One possible mechanism of this observed resistance is due to proteolytic shedding of cell surface proteins. For shedding events, MMP and ADAM metalloproteases (MPs) are[for full text, please go to the a.m. URL] ; SeriesInformation ; 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)